Summary CombiMatrix Corporation (CombiMatrix) is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNA-based testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Oligo Arrays with single nucleotide polymorphism (SNPs) and Oligo Arrays with SNPs for formalin-fixed, paraffin-embedded (FFPE) tissue. CombiMatrix is a CAP approved and CLIA-certified molecular diagnostic laboratory. CombiMatrix is headquartered in Irvine, California, the US. CombiMatrix Corporation (CBMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into... Research Beam Model: Research Beam Product ID: 713913 250 USD New
CombiMatrix Corporation (CBMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

CombiMatrix Corporation (CBMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : July   2016
  • Pages : 26
  • Publisher : GlobalData
 
 
 
Summary

CombiMatrix Corporation (CombiMatrix) is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNA-based testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Oligo Arrays with single nucleotide polymorphism (SNPs) and Oligo Arrays with SNPs for formalin-fixed, paraffin-embedded (FFPE) tissue. CombiMatrix is a CAP approved and CLIA-certified molecular diagnostic laboratory. CombiMatrix is headquartered in Irvine, California, the US.

CombiMatrix Corporation (CBMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
CombiMatrix Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
CombiMatrix Corporation, Medical Devices Deals, 2010 to YTD 2016 8
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
CombiMatrix Raises USD8 Million in Public Offering of Units 10
CombiMatrix to Raise USD5 Million in Private Placement of Securities 12
CombiMatrix to Raise USD3 Million in Private Placement of Warrants 14
CombiMatrix Completes Public Offering Of Units For US$12 Million 16
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million 18
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million 19
CombiMatrix Completes Private Placement Of Units For US$1.6 Million 20
CombiMatrix Completes Private Placement Of Units For US$7 Million 21
CombiMatrix Corporation - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List Of Tables
List of Tables
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Key Facts, 2015 1
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 1
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
CombiMatrix Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
CombiMatrix Corporation, Medical Devices Deals, 2010 to YTD 2016 8
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
CombiMatrix Raises USD8 Million in Public Offering of Units 10
CombiMatrix to Raise USD5 Million in Private Placement of Securities 12
CombiMatrix to Raise USD3 Million in Private Placement of Warrants 14
CombiMatrix Completes Public Offering Of Units For US$12 Million 16
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million 18
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million 19
CombiMatrix Completes Private Placement Of Units For US$1.6 Million 20
CombiMatrix Completes Private Placement Of Units For US$7 Million 21
CombiMatrix Corporation, Key Competitors 23
CombiMatrix Corporation, Key Employees 24
CombiMatrix Corporation, Subsidiaries 25
Lisst Of Figures
List of Figures
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
CombiMatrix Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
CombiMatrix Corporation, Medical Devices Deals, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter